Plasma growth hormone concentrations in Huntington's chorea

Area of Science:

• Neuroendocrinology
• Neurology
• Genetics

Background:

• Huntington's chorea is a progressive neurodegenerative disorder.
• Growth hormone (GH) plays a crucial role in metabolism and growth.
• Alterations in neuroendocrine function are increasingly recognized in neurodegenerative diseases.

Purpose of the Study:

• To investigate growth hormone secretion patterns in patients with Huntington's chorea.
• To compare GH response to glucose suppression and insulin stimulation tests between patients and controls.

Main Methods:

• Assessed early-morning fasting plasma growth hormone concentrations.
• Administered oral glucose and intravenous insulin to assess GH suppression and response.
• Compared hormonal profiles between nine Huntington's chorea patients and nine control subjects.

Main Results:

• Patients with Huntington's chorea showed abnormally high fasting growth hormone levels.
• GH suppression after oral glucose was irregular in patients, with exaggerated rebound phases.
• GH response to intravenous insulin showed a significantly faster rise in the first hour in patients.

Conclusions:

• Huntington's chorea is associated with dysregulated growth hormone secretion.
• The findings suggest potential neuroendocrine abnormalities contributing to the pathophysiology of Huntington's chorea.
• Further research is warranted to explore the clinical implications of these GH secretion abnormalities.